Managing BCMA Bispecifics in the Community

Uncategorized

Module

 

Managing BCMA Bispecifics in the Community

Description:
This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Learning Objectives

  • Explain the mechanism of action of BCMA bispecific antibodies
  • Identify key nursing responsibilities in therapy initiation, patient and caregiver education, and side effect management

Instructor:
Mary Steinbach, DNP, APRN

Publications:

Optimizing Transitions of Care in Multiple Myeloma Immunotherapy: Nurse Roles

BISPECIFIC ANTIBODY THERAPY: Exploring Efficacy, Safety, and Transition of Care Management

 

Videos:

Bispecifics in Multiple Myeloma | Myeloma University

Transitions of Care | Myeloma University 

Managing CRS, Neurotoxicity, and Infection | Myeloma University

 

For Patients:

Bispecifics: An Example with Elrexfio

Coordinating Your Bispecific Antibody Treatment | Myeloma Made Simple

Understanding Elfrexio (elranatamab-bcmm)

Understanding LYNOZYFIC™ (linvoseltamab-gcpt)

Understanding Tecvayli™ (teclistmab-cqyv)

Modules

Managing BCMA Bispecifics in the Community

This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Start Module

Managing CRS, Neurotoxicity, and Infection

Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.

Start Module

Transitions of Care

Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.

Start Module

Survivorship and Self Management

Learn about survivorship and self management strategies for multiple myeloma patients

Start Module

Bispecifics in Multiple Myeloma

Learn about the use of bispecific treatments in multiple myeloma

Start Module

Renal Impairment

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

Start Module

CAR-T Therapy

An exciting novel treatment for patients with myeloma 

Start Module

Monoclonal Antibodies

Using the patient’s own immune system to destroy myeloma cells.

Start Module

How Treatments Are Selected

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

Start Module

Myeloma Treatments - Part 1

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Start Module

Myeloma Treatments - Part 2

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

Start Module

Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.

Start Module
VIEW ALL MODULES

Managing CRS, Neurotoxicity, and Infection

Uncategorized

Module

 

Managing CRS, Neurotoxicity, and Infection

Description:
Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.

Learning Objectives:

  • Identify the signs, grading, and early management strategies for CRS and ICANS
  • Apply appropriate monitoring tools and interventions

Instructor:
Mary Steinbach, DNP, APRN

Publications:

BISPECIFIC ANTIBODY THERAPY: Exploring Efficacy, Safety, and Transition of Care Management

Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group

 Videos:

Bispecifics in Multiple Myeloma | Myeloma University

Transitions of Care | Myeloma University

For Patients:

Bispecifics: An Example with Elrexfio

Living Well with Myeloma: Infection Prevention and Management

Bispecific Antibodies: Early Side Effects

Bispecific Antibody Infection Management | Myeloma Made Simple

Modules

Managing BCMA Bispecifics in the Community

This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Start Module

Managing CRS, Neurotoxicity, and Infection

Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.

Start Module

Transitions of Care

Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.

Start Module

Survivorship and Self Management

Learn about survivorship and self management strategies for multiple myeloma patients

Start Module

Bispecifics in Multiple Myeloma

Learn about the use of bispecific treatments in multiple myeloma

Start Module

Renal Impairment

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

Start Module

CAR-T Therapy

An exciting novel treatment for patients with myeloma 

Start Module

Monoclonal Antibodies

Using the patient’s own immune system to destroy myeloma cells.

Start Module

How Treatments Are Selected

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

Start Module

Myeloma Treatments - Part 1

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Start Module

Myeloma Treatments - Part 2

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

Start Module

Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.

Start Module
VIEW ALL MODULES

Transitions of Care

Uncategorized

Module

 

Transitions of Care

Description:
Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.

Learning Objectives:

  • Identify key transition points requiring enhanced coordination
  • Describe best practices for effective handoffs.
  • Recognize patient and caregiver considerations

Instructor:
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO

Publications:

Optimizing Transitions of Care in Multiple Myeloma Immunotherapy: Nurse Roles

BISPECIFIC ANTIBODY THERAPY: Exploring Efficacy, Safety, and Transition of Care Management

Transition of Care Across the CAR T-Cell Therapy Continuum

Video:

Survivorship and Self Management in Multiple Myeloma | Myeloma University

For Patients:

Coordinating Care Made Simple: A Patient’s Guide

Modules

Managing BCMA Bispecifics in the Community

This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Start Module

Managing CRS, Neurotoxicity, and Infection

Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.

Start Module

Transitions of Care

Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.

Start Module

Survivorship and Self Management

Learn about survivorship and self management strategies for multiple myeloma patients

Start Module

Bispecifics in Multiple Myeloma

Learn about the use of bispecific treatments in multiple myeloma

Start Module

Renal Impairment

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

Start Module

CAR-T Therapy

An exciting novel treatment for patients with myeloma 

Start Module

Monoclonal Antibodies

Using the patient’s own immune system to destroy myeloma cells.

Start Module

How Treatments Are Selected

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

Start Module

Myeloma Treatments - Part 1

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Start Module

Myeloma Treatments - Part 2

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

Start Module

Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.

Start Module
VIEW ALL MODULES